TickerFactsScreenerDevelopers

Kura Oncology, Inc. (KURA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2007: $35.0K2008: $1.4K2009: -$18.6K2010: -$41.0K2011: -$68.0K2012: -$95.3K2013: -$124.0K2014: -$3.43M2015: $82.10M2016: $56.88M2017: $79.86M2018: $160.99M2019: $218.78M2020: $610.90M2021: $506.61M2022: $420.28M2023: $397.27M2024: $413.64M2025: $174.13M$174.13M
2007Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$174.13M-57.9%
2024$413.64M+4.1%
2023$397.27M-5.5%
2022$420.28M-17.0%
2021$506.61M-17.1%
2020$610.90M+179.2%
2019$218.78M+35.9%
2018$160.99M+101.6%
2017$79.86M+40.4%
2016$56.88M-30.7%
2015$82.10M+2491.6%
2014-$3.43M-2669.5%
2013-$124.0K-30.0%
2012-$95.3K-40.2%
2011-$68.0K-66.0%
2010-$41.0K-120.4%
2009-$18.6K-1428.3%
2008$1.4K-96.0%
2007$35.0K—